subject: Cnyd, H&r Block And Mslp Stock Update On Pennytobuck.com [print this page] MusclePharm to Pursue PEPFAR and Global Fund for HIV/AIDS Procurement of Recon
MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, reported the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development.
Cory Gregory, MusclePharms President stated We are thrilled to have Ms. Selbovitz join the MusclePharm team as we enter the therapeutic, nutritional supplementation market that is focused on products to meet the nutritional requirements of people living with HIV/AIDS.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution that invests the worlds money to battle disease. To date, it has committed US$19.3 billion in 144 countries to support large-scale prevention, treatment and care programs against these three diseases.
Mr. Gregory continued, We believe Ms. Selbovitz expertise and experience in the field of HIV will assist us secure distribution of MusclePharm products, such as Recon, to people living with the HIV disease in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR).
China Yida Holding Company (Nasdaq:CNYD), a leading diversified entertainment and media enterprise in China, has announced record financial results for the quarter ended June 30, 2010.
Media Business
Net revenue from the media business grew 18.2% to $9.3 million, compared with $7.9 million in the same period of last year.
Advertising revenue from FETV during the second quarter of 2010 was $7.9 million, approximately the same level as last year. The "Journey through China on the Train" infomercial program generated $1.4 million in revenue for the quarter, compared to no revenue in the second quarter of 2009 when the project was in development stage.
The nation's 1,990-page health care reform legislation is bound to cause confusion among business owners. Two leading local companies, H&R Block (NYSE:HRB) and Blue Cross and Blue Shield of Kansas City, have joined forces to provide a convenient, comprehensive tool to help small business owners understand the financial impact of health care reform.
The small business tax credit calculator is available through Blue Cross and Blue Shield of Kansas City and can be accessed by visiting www.BlueKCtaxcredit.com. The calculator and tax content were developed by The Tax Institute at H&R Block and also may be viewed by visiting www.thetaxinstitute.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).
